Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genasense available through Expanded Access Program for advanced melanoma

April 22, 2004

Bristol-Myers Squibb receives North American and Asian license for Javlor

April 22, 2004

CT-2106 enters phase I/II trial for colorectal cancer

April 22, 2004

Orphan medicinal product status for CA4P for anaplastic thyroid cancer

April 22, 2004

Three series of telomerase inhibitors described by researchers at Mitsui Chemicals

April 22, 2004

Janssen claims new alphav integrin inhibitors and their use in cancer, osteoporosis, etc.

April 22, 2004

Improved safety profile of pegylated liposomal doxorubicin in metastatic breast cancer

April 22, 2004

Significant prostate function improvements induced by an isoflavone red clover extract

April 22, 2004

Microtubule stabilizing agent potentiates anticancer activity in vitro

April 22, 2004

New data on AVP-893, a prototype of a novel class of antitumor agents from Avanir

April 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...